Literature DB >> 25516193

A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker.

Manal Al-Gethamy1, Victor M Corman2, Raheela Hussain3, Jaffar A Al-Tawfiq4, Christian Drosten2, Ziad A Memish5.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25516193      PMCID: PMC7108063          DOI: 10.1093/cid/ciu1135

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
To the Editor—The Middle East respiratory syndrome coronavirus (MERS-CoV) has caused outbreaks of severe respiratory infection in countries of the Arabian Peninsula since 2012. Although camels are known to carry the virus, many primary cases, including index cases in hospital outbreaks, had no contact with camels. Only 4.3% of a total 161 cases had camel contact in one report [1]. The size and duration of hospital outbreaks is surprising in view of the low rate of transmission in household contact situations [2]. Unrecognized transmission patterns might exist. During the Jeddah outbreak, a 40-year-old female nurse attended a 24-year-old, MERS-CoV–positive, symptomatic male patient for primary admission. The nurse wore a surgical mask and gloves but no other personal protective equipment during the admission procedures. Procedures performed on the patient included the insertion of a venous cannula, but no intubation or aerosol generating procedures were required. At that time, the Saudi Ministry of Health guidelines called for active screening of contacts of confirmed MERS cases in accordance with World Health Organization guidelines [3-5]. In accordance with these guidelines, the nurse was tested by reverse transcription polymerase chain reaction (RT-PCR) 2 days after exposure because of her occupational contact history. Despite the absence of symptoms, with positive test outcome in 2 different RT-PCR assays (upE and ORF 1A; Table 1), she was isolated at home and visited daily by infection control staff for follow-up from 12 April till 12 June 2014. RT-PCR tests were conducted at weekly intervals, with consistently positive results >5 weeks after the first sampling (Table 1). For confirmation, the first and last positive-testing samples were confirmed by an external laboratory at the University of Bonn, Germany. Positive tests using 2 different RT-PCR assays were confirmed. RT-PCR contamination was excluded by sequencing of approximately 2 kb of viral genomic RNA. Sequence comparison using single-nucleotide polymorphism patterns as described previously [6] revealed the presence of a virus strain typical for the Jeddah outbreak (737:C; 17836:T; 23953:G; 28778:A). Virus concentrations reflected as the inverse of Ct values over the course of home quarantine are shown in Table 1.
Table 1.

Timing, Symptoms, and Laboratory Results in a Case of Prolonged Subclinical Infection With the Middle East Respiratory Syndrome Coronavirus

Visit DateSymptomsRT-PCRCt Value
24 April 2014NonePositive35
29 April 2014NonePositive35
9 May 2014NonePositive34
21 May 2014NonePositive32
29 May 2014NonePositive30
30 May 2014NonePositive32
5 June 2014NonePositive35
12 June 2014NoneNegative0
14 June 2014NoneNegative0

Abbreviations: Ct, cycle threshold; RT-PCR, reverse transcription polymerase chain reaction.

Timing, Symptoms, and Laboratory Results in a Case of Prolonged Subclinical Infection With the Middle East Respiratory Syndrome Coronavirus Abbreviations: Ct, cycle threshold; RT-PCR, reverse transcription polymerase chain reaction. Our earlier study on transmission of MERS-CoV in household contacts revealed the possibility of MERS-CoV detection by RT-PCR in persons who are not symptomatic [2, 7]. In a second report 30% of asymptomatic case contacts were found to have identifiable virus in upper respiratory specimens on day 12 compared to 76% of cases [8]. The present case demonstrates that some individuals may be able to shed virus over prolonged periods of time, and without obvious symptoms preventing social activity. This group of individuals may include healthcare workers who would be able to transmit the virus to patients with predisposing conditions, with the consequence of apparent new infections. In addition to general measures to limit nosocomial spread via fomites, droplet transmission, or during aerosol-generating procedures, healthcare workers should be monitored for viral carriage to avoid prolongation of nosocomial outbreaks. These asymptomatic and prolonged shedders of MERS-CoV may lead to the appearance of new infections without clear transmission chains in patients who had been in hospital for >1 incubation period.
  6 in total

1.  Recovery from severe novel coronavirus infection.

Authors:  Ali M Albarrak; Gwen M Stephens; Roger Hewson; Ziad A Memish
Journal:  Saudi Med J       Date:  2012-12       Impact factor: 1.484

2.  Transmission of MERS-coronavirus in household contacts.

Authors:  Christian Drosten; Benjamin Meyer; Marcel A Müller; Victor M Corman; Malak Al-Masri; Raheela Hossain; Hosam Madani; Andrea Sieberg; Berend Jan Bosch; Erik Lattwein; Raafat F Alhakeem; Abdullah M Assiri; Waleed Hajomar; Ali M Albarrak; Jaffar A Al-Tawfiq; Alimuddin I Zumla; Ziad A Memish
Journal:  N Engl J Med       Date:  2014-08-28       Impact factor: 91.245

3.  Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013.

Authors: 
Journal:  Euro Surveill       Date:  2013-03-14

4.  An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014.

Authors:  Christian Drosten; Doreen Muth; Victor M Corman; Raheela Hussain; Malaki Al Masri; Waleed HajOmar; Olfert Landt; Abdullah Assiri; Isabella Eckerle; Ali Al Shangiti; Jaffar A Al-Tawfiq; Ali Albarrak; Alimuddin Zumla; Andrew Rambaut; Ziad A Memish
Journal:  Clin Infect Dis       Date:  2014-10-16       Impact factor: 9.079

5.  Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications.

Authors:  Ziad A Memish; Abdullah M Assiri; Jaffar A Al-Tawfiq
Journal:  Int J Infect Dis       Date:  2014-10-24       Impact factor: 3.623

6.  Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study.

Authors:  Z A Memish; J A Al-Tawfiq; H Q Makhdoom; A A Al-Rabeeah; A Assiri; R F Alhakeem; F A AlRabiah; S Al Hajjar; A Albarrak; H Flemban; H Balkhy; M Barry; S Alhassan; S Alsubaie; A Zumla
Journal:  Clin Microbiol Infect       Date:  2014-02-17       Impact factor: 8.067

  6 in total
  30 in total

Review 1.  Middle East Respiratory Syndrome Coronavirus and Children.

Authors:  Michael Bartenfeld; Stephanie Griese; Timothy Uyeki; Susan I Gerber; Georgina Peacock
Journal:  Clin Pediatr (Phila)       Date:  2016-11-23       Impact factor: 1.168

Review 2.  Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.

Authors:  Jasper F W Chan; Susanna K P Lau; Kelvin K W To; Vincent C C Cheng; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 3.  MERS coronavirus: diagnostics, epidemiology and transmission.

Authors:  Ian M Mackay; Katherine E Arden
Journal:  Virol J       Date:  2015-12-22       Impact factor: 4.099

4.  Middle East Respiratory Syndrome.

Authors:  Yaseen M Arabi; Hanan H Balkhy; Frederick G Hayden; Abderrezak Bouchama; Thomas Luke; J Kenneth Baillie; Awad Al-Omari; Ali H Hajeer; Mikiko Senga; Mark R Denison; Jonathan S Nguyen-Van-Tam; Nahoko Shindo; Alison Bermingham; James D Chappell; Maria D Van Kerkhove; Robert A Fowler
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

Review 5.  Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction.

Authors:  Ali S Omrani; Jaffar A Al-Tawfiq; Ziad A Memish
Journal:  Pathog Glob Health       Date:  2015       Impact factor: 2.894

Review 6.  Middle East respiratory syndrome: obstacles and prospects for vaccine development.

Authors:  Amy B Papaneri; Reed F Johnson; Jiro Wada; Laura Bollinger; Peter B Jahrling; Jens H Kuhn
Journal:  Expert Rev Vaccines       Date:  2015-04-11       Impact factor: 5.217

7.  MERS-CoV at the Animal-Human Interface: Inputs on Exposure Pathways from an Expert-Opinion Elicitation.

Authors:  Anna L Funk; Flavie Luce Goutard; Eve Miguel; Mathieu Bourgarel; Veronique Chevalier; Bernard Faye; J S Malik Peiris; Maria D Van Kerkhove; Francois Louis Roger
Journal:  Front Vet Sci       Date:  2016-10-05

8.  Epidemiology of a Novel Recombinant Middle East Respiratory Syndrome Coronavirus in Humans in Saudi Arabia.

Authors:  Abdullah M Assiri; Claire M Midgley; Glen R Abedi; Abdulaziz Bin Saeed; Malak M Almasri; Xiaoyan Lu; Hail M Al-Abdely; Osman Abdalla; Mutaz Mohammed; Homoud S Algarni; Raafat F Alhakeem; Senthilkumar K Sakthivel; Randa Nooh; Zainab Alshayab; Mohammad Alessa; Ganesh Srinivasamoorthy; Saeed Yahya AlQahtani; Ali Kheyami; Waleed Husein HajOmar; Talib M Banaser; Ahmad Esmaeel; Aron J Hall; Aaron T Curns; Azaibi Tamin; Ali Abraheem Alsharef; Dean Erdman; John T Watson; Susan I Gerber
Journal:  J Infect Dis       Date:  2016-06-14       Impact factor: 5.226

Review 9.  An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus.

Authors:  Ian M Mackay; Katherine E Arden
Journal:  Viruses       Date:  2017-12-02       Impact factor: 5.048

10.  Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014.

Authors:  Farida Ismail Al Hosani; Kimberly Pringle; Mariam Al Mulla; Lindsay Kim; Huong Pham; Negar N Alami; Ahmed Khudhair; Aron J Hall; Bashir Aden; Feda El Saleh; Wafa Al Dhaheri; Zyad Al Bandar; Sudhir Bunga; Kheir Abou Elkheir; Ying Tao; Jennifer C Hunter; Duc Nguyen; Andrew Turner; Krishna Pradeep; Jurgen Sasse; Stefan Weber; Suxiang Tong; Brett L Whitaker; Lia M Haynes; Aaron Curns; Susan I Gerber
Journal:  Emerg Infect Dis       Date:  2016-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.